Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes

NCT05641337 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT05641337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes
Lead sponsor
Huashan Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2022
Completion date
December 30, 2025
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, liver cirrhosis